Coley Pharmaceutical Group, Inc. (COLY) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 26 transactions totaling $2.0M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Jan 4, 2008 involved a transaction of 135,783 shares valued at $0.
No significant insider buying has been recorded for COLY in the recent period.
No significant insider selling has been recorded for COLY in the recent period.
Based on recent SEC filings, insider sentiment for COLY is bullish with an Insider Alignment Score of 84/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Coley Pharmaceutical Group, Inc. (COLY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading COLY stock, having executed 26 transactions in the past 90 days. The most active insider is James E. Thomas (Executive), who has made 5 transactions totaling $1.4M.
Get notified when executives and directors at COLY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 4, 2008 | E. Karobath Manfred | Executive | Tender | 135,783 | $N/A | $0 | |
| Jan 4, 2008 | L. Bratzler Robert | Executive | Tender | 308,697 | $N/A | $0 | |
| Jan 4, 2008 | L. Bratzler Robert | Executive | Tender | 150,654 | $N/A | $0 | |
| Jan 4, 2008 | M. Krieg Arthur | Executive | Tender | 5,240 | $N/A | $0 | |
| Jan 4, 2008 | M. Krieg Arthur | Executive | Tender | 545,602 | $N/A | $0 | |
| Jan 4, 2008 | M. Krieg Arthur | Executive | Tender | 5,240 | $N/A | $0 | |
| Jan 4, 2008 | M. Krieg Arthur | Executive | Tender | 5,240 | $N/A | $0 | |
| Dec 6, 2007 | E. Karobath Manfred | Executive | Sale | 27,000 | $7.93 | $214.1K | |
| Aug 29, 2007 | M. Krieg Arthur | Executive | Sale | 21,070 | $1.89 | $39.8K | |
| May 11, 2007 | E. Thomas James | Executive | Purchase | 60,000 | $8.66 | $519.6K | Large |
| May 10, 2007 | E. Thomas James | Executive | Purchase | 100,000 | $8.68 | $868.0K | Large |
| May 8, 2007 | E. Karobath Manfred | Executive | Purchase | 7,000 | $8.98 | $62.9K | |
| May 8, 2007 | E. Karobath Manfred | Executive | Purchase | 5,000 | $9.01 | $45.0K | |
| May 8, 2007 | E. Karobath Manfred | Executive | Purchase | 5,000 | $9.00 | $45.0K | |
| May 8, 2007 | E. Karobath Manfred | Executive | Purchase | 5,000 | $8.99 | $45.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $1.6M | 70.1% |
Disposition(D) | 1 | $352.5K | 15.1% |
Sale(S) | 4 | $319.5K | 13.7% |
Exercise(M) | 1 | $24.1K | 1.0% |
Tender(U) | 7 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Insiders at Coley Pharmaceutical Group, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 26 transactions totaling $1.6M in purchases versus $319.5K in sales, the net buying activity of $1.3M signals strong executive confidence. James E. Thomas (Executive) leads the buying activity with $1.4M in transactions across all time.